Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Life Science Sector Still In The Dark As UK-EU Trade Talks Make Progress

Industry Bemoans ‘Contradictory’ Guidance

Executive Summary

Hope is not lost as the EU sees a "narrow path" to a trade deal with the UK, but the life sciences industry is still facing uncertainty over key issues such as medicines batch testing.

You may also be interested in...



‘Public Health Crisis’ Warning For Northern Ireland Over Post-Brexit Guidance

With the likelihood of a UK-EU trade deal still in the balance, the UK life sciences industry has called for clarification from UK and EU regulators regarding the regulatory situation in Northern Ireland from next year.

‘Public Health Crisis’ Warning For Northern Ireland Over Post-Brexit Guidance

With the likelihood of a UK-EU trade deal still in the balance, the UK life sciences industry has called for clarification from UK and EU regulators regarding the regulatory situation in Northern Ireland from next year.

Brexit: Companies Must ‘Act Now’ To Avoid Drug Supply Disruptions In 2021

In its latest letter to medicines and medical product companies, the UK's Department of Health and Social Care says the biggest potential cause of disruption to supplies could be failure to prepare for border controls implemented by the EU member states after the end of the Brexit transition period.

Related Content

Topics

UsernamePublicRestriction

Register

OM008605

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel